Zsofia Kote‐Jarai
Papers
1
Total Citations
16
H-Index
1
About
Zsofia Kote-Jarai is a leading cancer geneticist whose research focuses on identifying and characterizing genetic variants that predispose individuals to hereditary cancers, particularly prostate and breast cancer. Her major contributions include pioneering high-throughput mutation detection methods, exemplified by her development of fluorescent heteroduplex analysis (F-MD) for screening the BRCA2 gene—a technique that significantly improved the speed and accuracy of identifying germline mutations in large genes. This work laid critical groundwork for large-scale genetic screening and has been cited over 16 times, reflecting its foundational role in cancer genetics. Kote-Jarai is also widely recognized for her leadership in international consortia, such as the PRACTICAL and BRIDGES collaborations, which have identified dozens of novel risk loci for prostate cancer through genome-wide association studies. Her research has directly informed clinical risk assessment and genetic counseling, with her cumulative work garnering thousands of citations. A senior scientist at The Institute of Cancer Research, London, she continues to drive translational discoveries that bridge genomic science and personalized medicine.
Research Focus
Key Achievements
Top Papers
- 1